相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes
P. Leon-Mimila et al.
DIABETES & METABOLISM (2021)
miR-21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy
Vera Usuelli et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease
Desh Raj et al.
PHARMACOLOGICAL RESEARCH (2020)
Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease
Nilaksh Gupta et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice
Kunpeng Wu et al.
BLOOD (2020)
Fibrosis: from mechanisms to medicines
Neil C. Henderson et al.
NATURE (2020)
Macrophages: versatile players in renal inflammation and fibrosis
Patrick Ming-Kuen Tang et al.
NATURE REVIEWS NEPHROLOGY (2019)
Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches
Svetoslav Chakarov et al.
SCIENCE (2019)
A Forward Chemical Genetic Screen Reveals Gut Microbiota Metabolites That Modulate Host Physiology
Haiwei Chen et al.
CELL (2019)
NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation
Shu Li et al.
EXPERIMENTAL CELL RESEARCH (2019)
PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation
Qisheng Lin et al.
REDOX BIOLOGY (2019)
Mechanisms of Renal Fibrosis
Benjamin D. Humphreys
ANNUAL REVIEW OF PHYSIOLOGY, VOL 80 (2018)
The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury
Hans-Joachim Anders et al.
KIDNEY INTERNATIONAL (2018)
Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential
Adam B. Roberts et al.
NATURE MEDICINE (2018)
Inflammasome-Independent Role of NLRP3 Mediates Mitochondrial Regulation in Renal Injury
Su-Mi Kim et al.
FRONTIERS IN IMMUNOLOGY (2018)
Depletion of Gut Microbiota Protects against Renal Ischemia-Reperfusion Injury
Diba Emal et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis
Gabriele Giacomo Schiattarella et al.
EUROPEAN HEART JOURNAL (2017)
Microbial metabolites in health and disease: Navigating the unknown in search of function
Kristina B. Martinez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
IL-36 Signaling Facilitates Activation of the NLRP3 Inflammasome and IL-23/IL-17 Axis in Renal Inflammation and Fibrosis
Hsi-Hua Chi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
NLRP3 Deficiency Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in a Mouse Unilateral Ureteral Obstruction Model of Chronic Kidney Disease
Honglei Guo et al.
MEDIATORS OF INFLAMMATION (2017)
Targeting Immunity in End-Stage Renal Disease
Ivano Baragetti et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden
Jason R. Stubbs et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota
A. Sloan Devlin et al.
CELL HOST & MICROBE (2016)
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Thomas A. Wynn et al.
IMMUNITY (2016)
An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice
Isis Ludwig-Portugall et al.
KIDNEY INTERNATIONAL (2016)
Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients
Cassianne Robinson-Cohen et al.
PLOS ONE (2016)
NLRP3 deletion protects against renal fibrosis and attenuates mitochondrial abnormality in mouse with 5/6 nephrectomy
Wei Gong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Monocyte and Macrophage Plasticity in Tissue Repair and Regeneration
Amitava Das et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis
Zeneng Wang et al.
CELL (2015)
The Dark Side of Extracellular ATP in Kidney Diseases
Anna Solini et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Mechanism of Prominent Trimethylamine Oxide (TMAO) Accumulation in Hemodialysis Patients
Xin Hai et al.
PLOS ONE (2015)
The contributory role of gut microbiota in cardiovascular disease
W. H. Wilson Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Macrophage heterogeneity in liver injury and fibrosis
Frank Tacke et al.
JOURNAL OF HEPATOLOGY (2014)
Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation
Brian J. Bennett et al.
CELL METABOLISM (2013)
Adiponectin Promotes Functional Recovery after Podocyte Ablation
Joseph M. Rutkowski et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Macrophage biology in development, homeostasis and disease
Thomas A. Wynn et al.
NATURE (2013)
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
Tony Jourdan et al.
NATURE MEDICINE (2013)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
The intestinal microbiota and host immune interactions in the critically ill
Tim J. Schuijt et al.
TRENDS IN MICROBIOLOGY (2013)
Activation and regulation of the inflammasomes
Eicke Latz et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Cellular and molecular mechanisms of renal fibrosis
Youhua Liu
NATURE REVIEWS NEPHROLOGY (2011)
The NLRP3 Inflammasome Promotes Renal Inflammation and Contributes to CKD
Akosua Vilaysane et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy
Robert L. Chevalier et al.
KIDNEY INTERNATIONAL (2009)
Macrophage diversity in renal injury and repair
Sharon D. Ricardo et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The management of CKD: A look into the future
A. Khwaja et al.
KIDNEY INTERNATIONAL (2007)
Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients - A phosphorous-31 magnetic resonance spectroscopy study
G Perseghin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects
R Paroni et al.
AMINO ACIDS (2005)
Pentoxifylline attenuated the renal disease progression in rats with remnant kidney
SL Lin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
分享论文
